Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'. (Q35837905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis' (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Chew GT

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

QJM: An International Journal of Medicine

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

537-548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Vascular signaling pathways in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Vascular function, insulin resistance and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Biochemical functions of coenzyme Q10

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Co-enzyme Q10: a new drug for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Coenzyme Q10 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Overview of the use of CoQ10 in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Control of arterial tone after long-term coenzyme Q10 supplementation in senescent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

PPARS, metabolic disease and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCH089

21 January 2018

Identifiers

DOI

10.1093/QJMED/HCH089

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15256611%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference